Related Experiment Videos
[Radiosynovectomy with dysprosium-165 iron hydroxide]
C Pirich1, A Wanivenhaus, W Graninger
1Universitätsklinik für Nuklearmedizin, Wien.
Acta Medica Austriaca
|January 1, 1993
Summary
165-Dysprosium ferric hydroxide macroaggregates show minimal leakage for treating rheumatoid synovitis. This radionuclide offers a safer alternative to 90-Yttrium for radiation synovectomy, reducing hospital stays.
Area of Science:
- Nuclear medicine
- Radiopharmacology
- Rheumatology